Form 4 holding
SVP, Chief Scientific Officer
Aprea Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 43,700
- Estimated value
- $160,855
- Report date
- 10 Mar 2022
- Price
- $3.68
- Ownership
- Direct
Lars B. Abrahmsen
Insider Reports History
- Reporting-owner location
- Boston, MA
- Latest reporting-owner signature
-
/s/ Scott M. Coiante, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Lars B. Abrahmsen
Form 4 holding
SVP, Chief Scientific Officer
Aprea Therapeutics, Inc.
- Security class
- Stock Option (right to Buy)
- Shares / value
- 100,000
- Estimated value
- Report date
- 10 Mar 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Lars B. Abrahmsen
4
APRE
Aprea Therapeutics, Inc.
- Report period
- 10 Mar 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 14 Mar 2022, 17:01
- Role
- SVP, Chief Scientific Officer
- Next action
- Open filing details
4
APRE
Aprea Therapeutics, Inc.
- Report period
- 01 Oct 2021
- Transactions
- 3
- Transaction value
- -$198,500
- Accepted by SEC
- 05 Oct 2021, 17:01
- Role
- SVP, Chief Scientific Officer
- Next action
- Open filing details
4
APRE
Aprea Therapeutics, Inc.
- Report period
- 20 Sep 2021
- Transactions
- 3
- Transaction value
- -$101,250
- Accepted by SEC
- 22 Sep 2021, 17:00
- Role
- SVP, Chief Scientific Officer
- Next action
- Open filing details